SELLAS Life Sciences Group (SLS) Accumulated Expenses: 2011-2024
Historic Accumulated Expenses for SELLAS Life Sciences Group (SLS) over the last 9 years, with Sep 2024 value amounting to $5.5 million.
- SELLAS Life Sciences Group's Accumulated Expenses fell 20.77% to $5.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.5 million, marking a year-over-year decrease of 20.77%. This contributed to the annual value of $7.7 million for FY2023, which is 21.70% up from last year.
- As of Q3 2024, SELLAS Life Sciences Group's Accumulated Expenses stood at $5.5 million, which was up 5.92% from $5.2 million recorded in Q2 2024.
- In the past 5 years, SELLAS Life Sciences Group's Accumulated Expenses registered a high of $7.7 million during Q4 2023, and its lowest value of $888,000 during Q1 2020.
- Moreover, its 3-year median value for Accumulated Expenses was $6.2 million (2023), whereas its average is $5.6 million.
- In the last 5 years, SELLAS Life Sciences Group's Accumulated Expenses soared by 186.82% in 2021 and then fell by 20.77% in 2024.
- Over the past 5 years, SELLAS Life Sciences Group's Accumulated Expenses (Quarterly) stood at $1.9 million in 2020, then surged by 38.00% to $2.6 million in 2021, then soared by 138.11% to $6.3 million in 2022, then grew by 21.70% to $7.7 million in 2023, then decreased by 20.77% to $5.5 million in 2024.
- Its Accumulated Expenses was $5.5 million in Q3 2024, compared to $5.2 million in Q2 2024 and $6.5 million in Q1 2024.